Artu Biologicals Deutschland Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Artu Biologicals Deutschland General Information

Description

Developer of pharmaceutical products. The company manufactures medicine and vaccines for allergy, anaemia, inflammation, thyroid, tumor and infectious disease.

Contact Information

Website
www.artu-deutschland.de
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Friedrich-Ebert-Damm 112
  • 22047 Hamburg
  • Germany
Primary Industry
Pharmaceuticals
Acquirer
Roelke Pharma
Corporate Office
  • Friedrich-Ebert-Damm 112
  • 22047 Hamburg
  • Germany

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Artu Biologicals Deutschland Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Artu Biologicals Deutschland‘s full profile, request access.

Request a free trial

Artu Biologicals Deutschland Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Artu Biologicals Deutschland‘s full profile, request access.

Request a free trial

Artu Biologicals Deutschland FAQs

  • When was Artu Biologicals Deutschland founded?

    Artu Biologicals Deutschland was founded in 2007.

  • Where is Artu Biologicals Deutschland headquartered?

    Artu Biologicals Deutschland is headquartered in Hamburg, Germany.

  • What industry is Artu Biologicals Deutschland in?

    Artu Biologicals Deutschland’s primary industry is Pharmaceuticals.

  • Is Artu Biologicals Deutschland a private or public company?

    Artu Biologicals Deutschland is a Private company.

  • What is Artu Biologicals Deutschland’s current revenue?

    The current revenue for Artu Biologicals Deutschland is .

  • Who are Artu Biologicals Deutschland’s investors?

    Fornix BioSciences has invested in Artu Biologicals Deutschland.

  • When was Artu Biologicals Deutschland acquired?

    Artu Biologicals Deutschland was acquired on 04-Jan-2011.

  • Who acquired Artu Biologicals Deutschland?

    Artu Biologicals Deutschland was acquired by Roelke Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »